Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2025 ,inter alia, to consider and approve 1) To Consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek has informed BSE that its Board of Directors will meet on Wednesday, May 7, 2025. The main agenda item is to consider and approve the audited financial results (both standalone and consolidated) for the fourth quarter and full financial year ended March 31, 2025. The notice also includes a standard 'any other business with the permission of the Chair' item. No financial figures, projections, or operational details are disclosed in this intimation, as is customary for pre-meeting notices under SEBI listing rules.
This is a routine regulatory filing with no direct impact on shareholders or stock price. Investors should watch for the actual Q4/FY25 results announcement expected on or after May 7, 2025 for meaningful performance insights.